Please enable JavaScript to continue using this application.

Compare $ALXO vs $TARA | Chartloom

Compare

$ALXO vs $TARA

ALX Oncology Holdings Inc · Protara Therapeutics Inc

ALXO

ALX Oncology Holdings Inc

TARA

Protara Therapeutics Inc

Compare $ALXO vs $TARA

Comparing ALX Oncology Holdings Inc and Protara Therapeutics Inc

ALXOALX Oncology Holdings Inc

TARAProtara Therapeutics Inc

ALXOALX Oncology Holdings Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

8.7%

52W performance

-36.5%

FCF yield

-42.2%

TARAProtara Therapeutics Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.8%

52W performance

-45.7%

FCF yield

-42.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALXO

TARA

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

TARA

Protara Therapeutics Inc

Market Cap

ALXO$168M

TARA$155M

Enterprise Value

ALXO$156M

TARA$138M

Price

ALXO$1.25

TARA$2.76

P/E Ratio

ALXON/A

TARAN/A

P/S Ratio

ALXO46.09x

TARA0.00x

EV/Sales

ALXO0.00x

TARA0.00x

EV/EBITDA

ALXO0.00x

TARA0.00x

P/B Ratio

ALXO1.24x

TARA0.99x

P/FCF Ratio

ALXON/A

TARAN/A

EV/FCF

ALXO-2.20x

TARA-2.07x

PEG Ratio

ALXON/A

TARAN/A

Forward P/E (NTM)

ALXON/A

TARAN/A

Forward P/S (NTM)

ALXON/A

TARAN/A

Revenue (TTM)

ALXO$0

TARA$0

Revenue Growth (YoY)

ALXON/A

TARAN/A

Forward Rev Growth

ALXO357.6%

TARA5488.8%

Gross Margin (TTM)

ALXO9.0%

TARA0.0%

Operating Margin (TTM)

ALXO0.0%

TARA0.0%

EBITDA Margin (TTM)

ALXO0.0%

TARA0.0%

Net Margin (TTM)

ALXO0.0%

TARA0.0%

FCF Margin (TTM)

ALXON/A

TARAN/A

Net Income (TTM)

ALXO$-81M

TARA$-70M

FCF (TTM)

ALXO$-71M

TARA$-66M

EPS (TTM)

ALXO-$0.60

TARA-$1.15

ROE (TTM)

ALXO-9030.0%

TARA-4172.0%

ROA (TTM)

ALXO-6728.0%

TARA-3878.0%

ROIC (TTM)

ALXO-8046.0%

TARA-4172.0%

Cash

ALXO$23M

TARA$17M

Debt

ALXO$11M

TARA$0

Net Cash/Debt

ALXO$12M

TARA$17M

Current Ratio (TTM)

ALXO9.71x

TARA10.97x

Quick Ratio (TTM)

ALXO9.44x

TARA10.81x

Debt/Equity (TTM)

ALXO0.08x

TARA0.00x

Debt/Assets (TTM)

ALXO0.0%

TARA0.0%

Interest Coverage (TTM)

ALXON/A

TARAN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

TARA0.00x

Beta

ALXO0.55

TARA1.54

52W Performance

ALXO-36.5%

TARA-45.7%

YTD Performance

ALXO8.7%

TARA-48.8%

% from 52W High

ALXO-53.0%

TARA-64.8%

% from 52W Low

ALXO19.0%

TARA9.8%

Asset Turnover (TTM)

ALXO0.00x

TARA0.00x

FCF Yield (TTM)

ALXO-42.2%

TARA-42.9%

Earnings Yield (TTM)

ALXO-48.1%

TARA-45.2%

Dividend Yield (TTM)

ALXON/A

TARAN/A

Rule of 40

ALXO0.0

TARA0.0

EV/GP/RG

ALXON/A

TARAN/A

Ticker research

View ALXO research View TARA research

Metric	ALXO ALX Oncology Holdings Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$168M	$155M
Enterprise Value	$156M	$138M
Price	$1.25	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	5488.8%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-81M	$-70M
FCF (TTM)	$-71M	$-66M
EPS (TTM)	-$0.60	-$1.15
ROE (TTM)	-9030.0%	-4172.0%
ROA (TTM)	-6728.0%	-3878.0%
ROIC (TTM)	-8046.0%	-4172.0%
Financial Health
Cash	$23M	$17M
Debt	$11M	$0
Net Cash/Debt	$12M	$17M
Current Ratio (TTM)	9.71x	10.97x
Quick Ratio (TTM)	9.44x	10.81x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.54
52W Performance	-36.5%	-45.7%
YTD Performance	8.7%	-48.8%
% from 52W High	-53.0%	-64.8%
% from 52W Low	19.0%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-42.9%
Earnings Yield (TTM)	-48.1%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View TARA research

Valuation

P/S Ratio

TARA

0.00x

ALXO

46.09x

EV/FCF

ALXO

-2.20x

TARA

-2.07x

Growth & revenue

Forward Revenue Growth

TARA

5488.8%

ALXO

357.6%

Profitability & performance

Gross Margin

ALXO

9.0%

TARA

0.0%

ROE

TARA

-4172.0%

ALXO

-9030.0%

FCF Yield %

ALXO

-42.2%

TARA

-42.9%

52-Week Performance

ALXO

-36.5%

TARA

-45.7%

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

TARA

Protara Therapeutics Inc

Market Cap

ALXO$168M

TARA$155M

Enterprise Value

ALXO$156M

TARA$138M

Price

ALXO$1.25

TARA$2.76

P/E Ratio

ALXON/A

TARAN/A

P/S Ratio

ALXO46.09x

TARA0.00x

EV/Sales

ALXO0.00x

TARA0.00x

EV/EBITDA

ALXO0.00x

TARA0.00x

P/B Ratio

ALXO1.24x

TARA0.99x

P/FCF Ratio

ALXON/A

TARAN/A

EV/FCF

ALXO-2.20x

TARA-2.07x

PEG Ratio

ALXON/A

TARAN/A

Forward P/E (NTM)

ALXON/A

TARAN/A

Forward P/S (NTM)

ALXON/A

TARAN/A

Revenue (TTM)

ALXO$0

TARA$0

Revenue Growth (YoY)

ALXON/A

TARAN/A

Forward Rev Growth

ALXO357.6%

TARA5488.8%

Gross Margin (TTM)

ALXO9.0%

TARA0.0%

Operating Margin (TTM)

ALXO0.0%

TARA0.0%

EBITDA Margin (TTM)

ALXO0.0%

TARA0.0%

Net Margin (TTM)

ALXO0.0%

TARA0.0%

FCF Margin (TTM)

ALXON/A

TARAN/A

Net Income (TTM)

ALXO$-81M

TARA$-70M

FCF (TTM)

ALXO$-71M

TARA$-66M

EPS (TTM)

ALXO-$0.60

TARA-$1.15

ROE (TTM)

ALXO-9030.0%

TARA-4172.0%

ROA (TTM)

ALXO-6728.0%

TARA-3878.0%

ROIC (TTM)

ALXO-8046.0%

TARA-4172.0%

Cash

ALXO$23M

TARA$17M

Debt

ALXO$11M

TARA$0

Net Cash/Debt

ALXO$12M

TARA$17M

Current Ratio (TTM)

ALXO9.71x

TARA10.97x

Quick Ratio (TTM)

ALXO9.44x

TARA10.81x

Debt/Equity (TTM)

ALXO0.08x

TARA0.00x

Debt/Assets (TTM)

ALXO0.0%

TARA0.0%

Interest Coverage (TTM)

ALXON/A

TARAN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

TARA0.00x

Beta

ALXO0.55

TARA1.54

52W Performance

ALXO-36.5%

TARA-45.7%

YTD Performance

ALXO8.7%

TARA-48.8%

% from 52W High

ALXO-53.0%

TARA-64.8%

% from 52W Low

ALXO19.0%

TARA9.8%

Asset Turnover (TTM)

ALXO0.00x

TARA0.00x

FCF Yield (TTM)

ALXO-42.2%

TARA-42.9%

Earnings Yield (TTM)

ALXO-48.1%

TARA-45.2%

Dividend Yield (TTM)

ALXON/A

TARAN/A

Rule of 40

ALXO0.0

TARA0.0

EV/GP/RG

ALXON/A

TARAN/A

Ticker research

View ALXO research View TARA research

Metric	ALXO ALX Oncology Holdings Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$168M	$155M
Enterprise Value	$156M	$138M
Price	$1.25	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	5488.8%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-81M	$-70M
FCF (TTM)	$-71M	$-66M
EPS (TTM)	-$0.60	-$1.15
ROE (TTM)	-9030.0%	-4172.0%
ROA (TTM)	-6728.0%	-3878.0%
ROIC (TTM)	-8046.0%	-4172.0%
Financial Health
Cash	$23M	$17M
Debt	$11M	$0
Net Cash/Debt	$12M	$17M
Current Ratio (TTM)	9.71x	10.97x
Quick Ratio (TTM)	9.44x	10.81x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.54
52W Performance	-36.5%	-45.7%
YTD Performance	8.7%	-48.8%
% from 52W High	-53.0%	-64.8%
% from 52W Low	19.0%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-42.9%
Earnings Yield (TTM)	-48.1%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View TARA research